MRNA vaccine against SARS-CoV-2 response is comparable between patients on dialysis and healthy controls after adjustment for age, gender and history of COVID-19 infection.

ABSTRACT:

SUBMITTER: Rostoker G 

PROVIDER: S-EPMC11903638 | biostudies-literature | 2025 Jan

REPOSITORIES: biostudies-literature